Loading…
This event has ended. Visit the official site or create your own event on Sched.
View analytic
Saturday, September 16 • 3:15pm - 4:30pm
Examining the Limitations of Monoamine-Directed Therapy in Major Depressive Disorder: Novel Mechanisms and Treatment Targets

Sign up or log in to save this to your schedule and see who's attending!

Recent research into the pathophysiology of MDD is revealing novel treatment targets that go beyond monoamines and include other targets, such as glutamate neurotransmission (e.g. ketamine and other modulators); modulation of cholinergic and gamma-aminobutyric acid (GABA)-ergic transmission; neuronal plasticity; stress/hypothalamic pituitary adrenal (HPA)-axis; neuroinflammation; and the reward system via modulation of opioid receptors and beta endorphins. In this session, Dr. Maletic will compare the safety and efficacy of novel MDD agents and their complementary role within the current treatment armamentarium.

Supported by an educational grant from Alkermes, Inc. 


Speakers
avatar for Vladimir Maletic, MD, MS

Vladimir Maletic, MD, MS

Psych Congress Steering Committee Member; Clinical Professor of Psychiatry and Behavioral Science, University of South Carolina School of Medicine, Greenville, South Carolina | | Vladimir Maletic, MD, MS, is a clinical professor of neuropsychiatry and behavioral science at the U... Read More →


Saturday September 16, 2017 3:15pm - 4:30pm
Hall E-2 The New Orleans Ernest N. Morial Convention Center 900 Convention Center Boulevard New Orleans, LA 70130